Health system leaders have long been interested in figuring out ways to monetize clinical data. It makes sense: if they could sell or license de-identified data in their EHRs to life science or tech companies, that would be very helpful from a revenue diversification perspective. Especially whenever core inpatient economics are under siege.  But, it’s always been an easier-said-than-done proposition. And now, maybe there's also a new spoiler in the mix, in the form of 'synthe